Peptides, From First Principles
The chemistry is settled and genuinely elegant. The marketplace built on top of it is where the evidence stops being uniform — and the word "peptide" does a lot of work hiding that.
Signalling molecules, not steroids — a field where the biochemistry is settled and the marketplace is not.
The chemistry is settled and genuinely elegant. The marketplace built on top of it is where the evidence stops being uniform — and the word "peptide" does a lot of work hiding that.
For most compounds in this category there is no human safety data at all. That is the headline, not a footnote — and it changes what a safety article can responsibly say.
The most preventable harm in this category is not pharmacological. It is a unit conversion done wrong — and the same mistake, made the same way, produces a dose a thousand times too large.
The standard guidance is a mix of genuine sterile compounding practice and folklore repeated until it hardened. The two are worth separating, because only one of them prevents infections.
Route-of-administration guides for peptides circulate with impressive precision — bioavailability percentages, dose multipliers, brain-level comparisons. Most of those numbers have no study behind them.
Subcutaneous technique is standard patient-education material and worth getting right. The failure modes are specific, well documented, and almost entirely preventable.
Reconstituting a vial starts two timers that measure completely different things. Almost every storage guide collapses them into one number, and that conflation is where the confusion lives.